Back to Blog

    The LIPLEG Trial: What The Lancet's 2026 Study Means for Women with Lipoedema

    Prof. Dr. Mehmet Veli Karaaltın September 7, 2026 6 min read

    For decades, women with lipoedema were told the same thing: wear compression, attend manual lymphatic drainage, and accept the pain. Surgery was offered, but without high-quality randomised evidence behind it. That changed in September 2026, when The Lancet published the results of the German LIPLEG trial (Podda et al., Lancet 2026;408:910–23).

    What the LIPLEG trial actually did

    LIPLEG was a multicentre, randomised, assessor-blinded trial run across 11 German centres and registered as NCT04272827. Women with stage I, II or III lipoedema and leg pain of at least 4 out of 10 first received conservative complex decongestive therapy for up to seven months. Only then were they randomly assigned, in a 2:1 ratio, either to liposuction or to continued conservative therapy.

    Of 1,973 women screened between January 2021 and June 2022, 453 were enrolled and 410 were randomised — 278 to liposuction and 132 to conservative therapy. Mean age was 42.9 years. To keep the assessors blinded, patches were applied to every patient''s legs at assessment visits, whether or not they had been operated on.

    The results

    The primary endpoint was a reduction in patient-reported leg pain of at least 2 points at 12 months, with any missing assessment counted as a failure.

    • 190 of 278 women (68%) in the liposuction group reached that threshold.
    • 10 of 132 women (8%) in the conservative therapy group did.
    • Odds ratio 26.2 (95% CI 13.1–52.5), p<0.0001.
    • Quality-of-life secondary endpoints also improved more after surgery.

    This is the largest and most rigorous comparison we have, and the size of the difference is unusual in surgical research.

    The part that must not be skipped: safety

    Liposuction was not risk-free. Adverse events occurred in 124 of 265 operated patients (47%), and 20 of those 265 (8%) were classified as serious. In the conservative group, 30 of 145 patients (21%) reported adverse events and five (3%) were serious. In other words, the benefit was large, and so was the responsibility that comes with offering the operation.

    My reading as a surgeon is straightforward: LIPLEG supports lipoedema liposuction as an effective treatment, not as a casual one. Case selection, staged operating, volume discipline, lymphatic-sparing technique and structured aftercare are what keep the complication side of that equation acceptable. A 36-month follow-up of the trial cohort is still running, and it will tell us how durable the pain relief is.

    What this changes for patients

    If you have been living with symmetrical, painful, easily bruising fat in the legs that does not respond to diet or exercise, three things follow from this trial:

    1. Your pain is a medical symptom, not a cosmetic complaint. LIPLEG measured pain as its primary outcome, which is how lipoedema should be judged.
    2. Conservative therapy first is still reasonable — every woman in the trial had it before randomisation — but it should not be an indefinite waiting room.
    3. Surgery should be discussed with numbers: roughly two in three women achieved meaningful pain reduction; roughly one in twelve had a serious adverse event.

    How we approach lipoedema surgery in Istanbul

    Our protocol reflects the same principles the trial centres used: confirmed clinical diagnosis and staging, documented conservative therapy, assessment of lymphatic function, staged sessions rather than one oversized operation, tumescent lymph-sparing liposuction, and compression plus lymphatic drainage during recovery. Patients travelling internationally are planned so that each stage has proper follow-up rather than a single rushed trip.

    Reference: Podda M, Schmidt J, Cornely ME, et al. Liposuction versus conservative therapy for patients with lipoedema in Germany: a multicentre, randomised controlled clinical trial. Lancet 2026;408:910–23.

    What this means for patients in the UK

    Lipoedema surgery is rarely funded on the NHS: most trusts treat liposuction as a cosmetic procedure and Individual Funding Requests are usually refused unless conservative care has clearly failed and is fully documented. Private UK costs typically run into five figures across the staged procedures a full treatment needs. The LIPLEG evidence strengthens an IFR application, and it is also why many UK patients from London, Manchester, Birmingham and Glasgow now travel for staged lymph-sparing surgery. Istanbul is roughly a four-hour direct flight from most UK airports.

    What this means for patients in the United States

    In the US, lipoedema liposuction is increasingly argued as reconstructive rather than cosmetic, and some insurers now approve it with documented conservative therapy, photographs and a specialist diagnosis. Coverage remains inconsistent, and out-of-pocket costs for multi-stage surgery are high. A randomised trial published in The Lancet gives appeals stronger footing, and for self-pay patients from New York, Miami, Los Angeles and Chicago it also makes an internationally staged plan a realistic option.

    Talk to the clinic

    Every plan starts with a video consultation before any travel is booked. Contact the clinic to arrange one, or read our guide on how lipoedema surgery is staged and recovered.

    What LIPLEG changes for a UK funding request

    Until now, refusals often leaned on the argument that liposuction for lipoedema was cosmetic and unproven. LIPLEG is a randomised controlled trial published in The Lancet, which is the level of evidence funding panels ask for. If you are preparing an Individual Funding Request, cite the trial by name, attach your staging diagnosis, and document the conservative therapy you have already completed.

    Does insurance cover lipedema surgery in the US?

    Some US insurers now approve lipedema reduction surgery when the file shows a formal diagnosis, stage, photographs, failed conservative treatment over several months and a functional impact on mobility or pain. Others still classify it as cosmetic. Ask your insurer for their written medical policy on lipedema before you build the file, then supply exactly what it lists.

    Where cost sits in the decision

    Patients comparing lipedema liposuction cost between the UK, the US and Istanbul should compare like for like: number of sessions planned, whether general anaesthesia and a hospital night are included, compression garments, and follow-up. A single low headline figure that covers one session of one region is not cheaper — it is a smaller operation.

    Ask the clinic for a staged plan with the sessions and inclusions written out.

    Considering this procedure?

    Book a private consultation with Prof. Dr. Mehmet Veli Karaaltın for a personalised surgical plan.

    Speak to the clinic

    Patients travel from the UK, Ireland and the United States for treatment in Istanbul. Video consultations are held before you book any travel.

    Prof. Dr. Mehmet Veli Karaaltın Clinic
    Teşvikiye, Sakayık Sk. No:47
    34365 Şişli / Istanbul, Turkey
    LIPLEG triallipedema liposuctionlipedema surgery costdoes insurance cover lipedema surgerylipedema liposuction costlipoedema surgery UKlipedema surgery abroadlymph sparing liposuction